Claritev price target lowered to $30 from $33 at Wells Fargo

Wells Fargo analyst Stan Berenshteyn, lowered the firm’s price target on Claritev (CTEV) to $30 from $33 and keeps an Equal Weight rating on the shares. While 2026 guidance midpoint was shy of estimates, the guided range appears to capture uncertainty inherent in 85% of revenue driven by volumes, the firm says. Wells recalibrates estimates lower, but the model now feels on better footing to see upward revisions.